Report: Teen HPV vaccination rate still lagging

July 25, 2013 by Mike Stobbe

(AP)—Disappointed health officials say only about half of teenage girls have gotten a controversial vaccine against cervical cancer—a rate that's changed little in three years.

The Centers for Disease Control and Prevention reported Thursday that about 54 percent of teenage girls have received at least one dose of the expensive three-shot vaccine. The shots protect against , or HPV. The sexually transmitted bug can cause and .

The vaccine was introduced in 2006, and is recommended at ages 11 and 12. Some experts think parents are uneasy with the sexual issues it raises, and doctors and states have hesitated to promote it or require it for school attendance.

The new report is based on a telephone survey.

Explore further: Teen vaccinations against cervical cancer lagging

Related Stories

Teen vaccinations against cervical cancer lagging

August 25, 2011

(AP) -- Only about half of the teenage girls in the U.S. have rolled up their sleeves for a controversial vaccine against cervical cancer - a rate well below those for two other vaccinations aimed at adolescents.

Too few girls get HPV vaccine against cancer: CDC

August 30, 2012

(HealthDay)—Parents and doctors can do more to protect girls from cancers caused by the human papillomavirus (HPV), say U.S. health officials who are concerned by lagging HPV vaccination rates among females.

Sexually transmitted HPV declines in US teens

June 19, 2013

The number of US girls with the sexually transmitted disease HPV has dropped by about half even though relatively few youths are getting the vaccine, research showed on Wednesday.

Recommended for you

Malaria vaccine provides hope for a general cure for cancer

October 13, 2015

The hunt for a vaccine against malaria in pregnant women has provided an unexpected side benefit for Danish researchers, namely what appears to be an effective weapon against cancer. The scientists behind the vaccine aim ...

Breast cancer drug beats superbug

October 13, 2015

Researchers at University of California, San Diego School of Medicine and Skaggs School of Pharmacy and Pharmaceutical Sciences have found that the breast cancer drug tamoxifen gives white blood cells a boost, better enabling ...

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

1 / 5 (2) Jul 26, 2013
Great news! At least some are smart enough not to be damaged by this useless treatment!

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.